Treatment for Livedoid Vasculopathy

医学 梅德林 英语 皮肤病科 外科 内科学 儿科 政治学 法学 哲学 语言学
作者
Robert Micieli,Afsáneh Alavi
出处
期刊:JAMA Dermatology [American Medical Association]
卷期号:154 (2): 193-193 被引量:82
标识
DOI:10.1001/jamadermatol.2017.4374
摘要

Importance

Livedoid vasculopathy is a painful, ulcerative condition of the lower extremities for which no established treatment exists. Current treatment paradigms rely on low levels of evidence, primarily case reports and case series.

Objective

To systematically review the treatment for livedoid vasculopathy and synthesize the available clinical data.

Evidence Review

A systematic review of the literature using Ovid MEDLINE (covering the period January 1, 1946, through June 9, 2017) and Ovid EMBASE (covering January 1, 1947, through June 9, 2017) databases was performed with a broad and inclusive search strategy along with a subsequent search of the references of retrieved articles. All case series reports published in the English language and in a peer-reviewed journal discussing the treatment for livedoid vasculopathy diagnosis were included.

Findings

A total of 29 case series reports published in the English language and in a peer-reviewed journal discussed the treatment for livedoid vasculopathy. These reports represented a total of 339 patients, of whom 230 (68%) were female and 69 (20%) were male; sex was not stated for 40 patients. Treatment with anticoagulants, antiplatelets, anabolic steroids, thrombolytics, hyperbaric oxygen, intravenous immunoglobulins, vitamin supplementation, UV light, and a combination of 1 or more of these among other therapies had a favorable outcome. Anticoagulants were the most commonly used monotherapy, achieving a favorable response in 62 of 63 patients (98%). Anabolic steroids, intravenous immunoglobulins, and antiplatelets were the second, third, and fourth most commonly used treatments, respectively. All of these therapies were associated with good clinical outcomes. Adverse events were observed in 44 patients (13%).

Conclusions and Relevance

A variety of treatments with varying degrees of success have been used to treat livedoid vasculopathy. Randomized clinical trials should be performed in the future to better establish these treatments in clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
852应助zhying55采纳,获得10
1秒前
2秒前
顶级洋仔完成签到,获得积分10
2秒前
CYT完成签到,获得积分20
3秒前
有话好好硕完成签到 ,获得积分10
4秒前
汉堡包应助小饭采纳,获得10
5秒前
Dawn完成签到,获得积分10
5秒前
啦啦啦发布了新的文献求助10
5秒前
lh发布了新的文献求助10
5秒前
哈密瓜牛奶完成签到,获得积分10
6秒前
6秒前
梓枫完成签到,获得积分10
7秒前
橙子发布了新的文献求助30
8秒前
yuyan发布了新的文献求助10
8秒前
XXX完成签到,获得积分10
11秒前
young发布了新的文献求助10
13秒前
13秒前
15秒前
Chocolate发布了新的文献求助10
16秒前
jenningseastera应助简单河马采纳,获得30
18秒前
qqqqqq发布了新的文献求助10
20秒前
胡多完成签到 ,获得积分10
22秒前
搜集达人应助whitedawn采纳,获得10
22秒前
Chocolate完成签到,获得积分10
22秒前
emile发布了新的文献求助10
23秒前
赘婿应助dgsxl采纳,获得10
23秒前
25秒前
26秒前
研友_VZG7GZ应助sunzhuxi采纳,获得10
29秒前
不不发布了新的文献求助10
29秒前
30秒前
30秒前
mm发布了新的文献求助20
33秒前
风中黎昕完成签到 ,获得积分10
34秒前
happyccch发布了新的文献求助30
35秒前
35秒前
温暖的靖发布了新的文献求助10
36秒前
37秒前
38秒前
哈桑士发布了新的文献求助20
38秒前
高分求助中
Worked Bone, Antler, Ivory, and Keratinous Materials 1000
Mass producing individuality 600
Algorithmic Mathematics in Machine Learning 500
Разработка метода ускоренного контроля качества электрохромных устройств 500
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
Advances in Underwater Acoustics, Structural Acoustics, and Computational Methodologies 300
Limes XXIII Sonderband 4 / II Proceedings of the 23rd International Congress of Roman Frontier Studies Ingolstadt 2015 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3829200
求助须知:如何正确求助?哪些是违规求助? 3371893
关于积分的说明 10469615
捐赠科研通 3091524
什么是DOI,文献DOI怎么找? 1701149
邀请新用户注册赠送积分活动 818199
科研通“疑难数据库(出版商)”最低求助积分说明 770753